methamphetamine has been researched along with Genetic Predisposition in 64 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 26 (40.63) | 29.6817 |
2010's | 33 (51.56) | 24.3611 |
2020's | 5 (7.81) | 2.80 |
Authors | Studies |
---|---|
Beierle, JA; Bryant, CD; Chen, MM; Goldberg, LR; Homanics, GE; Johnson, WE; Kelliher, JC; Kirkpatrick, SL; Mulligan, MK; Parks, C; Reed, ER; Williams, RW; Wu Cox, J; Yao, EJ | 1 |
Chen, W; Gu, J; Hong, Q; Li, L; Liu, H; Liu, Y; Shen, W; Wu, T; Xie, X; Xu, W; Xu, Z; Zhou, W; Zhuang, D | 1 |
Deng, XD; Liu, H; Liu, Y; Ma, Y; Zhang, W | 1 |
Berk, M; Guerin, AA; Kim, JH; Lawrence, AJ; Nestler, EJ; Rossell, SL | 1 |
Dalton, CF; Fachim, H; Iamjan, SA; Nudmamud-Thanoi, S; Reynolds, GP; Thanoi, S; Watiktinkorn, P | 1 |
Eastwood, EC; Eshleman, AJ; Janowsky, A; Phillips, TJ | 1 |
Iamjan, SA; Nudmamud-Thanoi, S; Reynolds, GP; Thanoi, S; Watiktinkorn, P | 1 |
Huang, ET; Huckans, M; Hudson, R; Loftis, JM; Phillips, TJ; Wilhelm, CJ | 1 |
Bousman, C; Cherner, M; Everall, I; Halpin, LE; Minassian, A; Murray, SS; Saloner, R; Vaida, F; Watson, CW | 1 |
Hatim, A; Mohamed, Z; Reynolds, GP; Sim, MS | 1 |
Aleksic, B; Aoyama-Uehara, K; Hashimoto, R; Ikeda, M; Iwata, N; Iyo, M; Kawamura, Y; Kondo, N; Miyagawa, T; Naruse, N; Nishida, N; Okahisa, Y; Ozaki, N; Sasaki, T; Sora, I; Takeda, M; Tokunaga, K; Ujike, H; Won, M | 1 |
Albertson, TE; Diercks, DB; Gaedigk, A; Mills, LD; Owen, KP; Southard, J; Sutter, ME | 1 |
Allen, CN; Belknap, JK; Derkach, VA; Olsen, RH; Phillips, TJ; Raber, J | 1 |
Baba, H; Belknap, JK; Burkhart-Kasch, S; Hitzemann, R; Li, N; McKinnon, CS; McWeeney, S; Phillips, TJ; Reed, C; Scibelli, AC | 1 |
Haerian, BS | 1 |
Gelernter, J; Kalayasiri, R; Malison, RT; Mutirangura, A; Verachai, V | 1 |
Barkley-Levenson, AM; Eastwood, EC; Phillips, TJ | 1 |
Han, B; He, J; Lu, Y; Su, H; Sun, H; Tao, J; Wang, Y; Wei, Y; Wu, W; Xie, Y; Xu, K; Zhang, J; Zhang, X; Zhang, Y; Zou, S | 1 |
Arai, T; Hasegawa, J; Hashimoto, R; Hayashida, M; Ikeda, K; Inada, T; Irukayama-Tomobe, Y; Itokawa, M; Iwata, N; Iyo, M; Kasai, S; Katoh, R; Kondo, N; Mori, S; Muramatsu, M; Nagashima, M; Naka-Mieno, M; Naruse, N; Nishizawa, D; Ohi, K; Ozaki, N; Saito, YC; Sakurai, T; Sato, N; Satoh, Y; Sawabe, M; Sora, I; Sugimura, H; Tagami, M; Tanaka, M; Tanioka, F; Tanisawa, K; Uehara-Aoyama, K; Ujike, H; Won, MJ; Yamada, H; Yamada, M; Yamada, Y | 1 |
Duan, S; Ji, H; Li, L; Liu, G; Liu, H; Shen, W; Wang, Q; Xie, X; Xu, X; Zhou, W | 1 |
Dimatelis, JJ; Kellaway, LA; Mpeta, B; Russell, VA; Stein, DJ; Womersley, JS | 1 |
Abdolmaleky, HM; Barati, M; Ghadirivasfi, M; Ghasemzadeh, MR; Joghataei, M; Mehrabi, S; Mousavi-Behbahani, Z; Narimani, S; Nohesara, S; Soleimani, M; Taban, M; Thiagalingam, S | 1 |
Akinyeke, T; Baker, EJ; Daunais, JB; Davenport, AT; Raber, J; Weber, SJ | 1 |
Harano, M; Hashimoto, K; Inada, T; Iwata, N; Iyo, M; Kanahara, N; Komiyama, T; Miyatake, R; Ozaki, N; Sekine, Y; Sora, I; Ujike, H; Yamada, M | 1 |
Harano, M; Hori, T; Inada, T; Iwata, N; Iyo, M; Kishimoto, M; Komiyama, T; Kotaka, T; Kuroda, S; Morita, Y; Okahisa, Y; Ozaki, N; Sekine, Y; Sora, I; Ujike, H; Yamada, M | 1 |
Anitha, A; Ezaki, N; Harano, M; Inada, T; Iwata, N; Iwata, Y; Iyo, M; Kawai, M; Komiyama, T; Mori, N; Nakamura, K; Sekine, Y; Sora, I; Suzuki, K; Takebayashi, K; Takei, N; Thanseem, I; Ujike, H; Yamada, M | 1 |
Aleksic, B; Harano, M; Hori, T; Ikeda, M; Inada, T; Iwata, N; Iyo, M; Kawashima, K; Kinoshita, Y; Kishi, T; Kitajima, T; Komiyama, T; Ohkouchi, T; Ozaki, N; Sekine, Y; Sora, I; Ujike, H; Yamada, M; Yamanouchi, Y | 1 |
Nabeshima, T; Niwa, M; Yan, Y | 1 |
Inada, T; Iwata, N; Iyo, M; Katsu, T; Kodama, M; Kuroda, S; Okahisa, Y; Ozaki, N; Sora, I; Takaki, M; Uchimura, N; Ujike, H; Yamada, M | 1 |
Anitha, A; Harano, M; Inada, T; Iwata, N; Iwata, Y; Iyo, M; Komiyama, T; Mori, N; Nakamura, K; Ozaki, N; Sekine, Y; Sora, I; Suzuki, K; Takei, N; Ujike, H; Yamada, M | 1 |
Inada, T; Iwata, N; Iyo, M; Kodama, M; Kotaka, T; Kuroda, S; Nakata, K; Okahisa, Y; Ozaki, N; Sora, I; Takaki, M; Uchimura, N; Ujike, H; Yamada, M | 1 |
Burkhart-Kasch, S; Cunningham, CL; Franken, FH; Hashimoto, JG; Janowsky, A; Li, N; Phillips, TJ; Reed, C; Scibelli, AC; Wheeler, JM; Wiren, KM | 1 |
Bryant, CD; Chang, HP; Palmer, AA; Tarantino, LM; Wiltshire, T; Zhang, J | 1 |
Inada, T; Iwata, N; Iyo, M; Kawashima, K; Kinoshita, Y; Kishi, T; Kitajima, T; Naitoh, H; Okochi, T; Okumura, T; Ozaki, N; Sora, I; Tsunoka, T; Uchimura, N; Ujike, H; Yamada, M; Yamanouchi, Y | 1 |
Atkinson, JH; Bousman, CA; Cherner, M; Everall, IP; Glatt, SJ; Grant, I; Tsuang, MT | 1 |
Inada, T; Iwata, N; Iyo, M; Kawashima, K; Kishi, T; Kitajima, T; Okochi, T; Okumura, T; Ozaki, N; Sora, I; Tsunoka, T; Uchimura, N; Ujike, H; Yamada, M | 1 |
Hara, K; Kageura, M; Kashiwagi, M; Kubo, S; Matsusue, A; Sugimura, T | 1 |
Baba, H; Burkhart-Kasch, S; Li, N; McKinnon, CS; Phillips, TJ; Reed, C; Scibelli, AC; Wheeler, JM | 1 |
Chiang, YH; Hoffer, B; Kuang, SY; Luo, Y; Wang, Y | 1 |
Bousman, CA; Chana, G; Cherner, M; Deutsch, R; Ellis, RJ; Everall, IP; Grant, I; Gupta, S; Heaton, RK | 1 |
Correll, CU; Inada, T; Iwata, N; Iyo, M; Kishi, T; Kitajima, T; Okochi, T; Ozaki, N; Sora, I; Uchimura, N; Ujike, H; Yamada, M | 1 |
Bevins, RA; Carlo, G; Gendelman, HE; Grant, KM; LeVan, TD; Li, M; Stoltenberg, SF; Wells, SM | 1 |
Alda, M; Beranek, M; Hosák, L; Serý, O | 1 |
Barnes, MR; Breen, G; Chen, CK; Collier, DA; Jugurnauth, SK; Li, T; Lin, SK; Liu, HC | 1 |
Bryant, CD; Guido, MA; Kole, LA; Palmer, AA; Sokoloff, G | 1 |
Chomchai, C; Manaboriboon, B | 1 |
London, ED; McCracken, JT; Nurmi, EL; Payer, DE; Wilson, SA | 1 |
Gururajan, A; Klug, M; Manning, EE; van den Buuse, M | 1 |
Harano, M; Inada, T; Iyo, M; Katsu, T; Komiyama, T; Nakata, K; Nomura, A; Ozaki, N; Sekine, Y; Sora, I; Ujike, H; Yamada, M | 1 |
Geyer, MA; Kuczenski, R; Lohr, JB; Niculescu, AB; Ogden, CA; Paulus, MP; Rich, ME; Schork, NJ | 1 |
Harano, M; Imamura, T; Inada, T; Iwata, N; Iyo, M; Kishimoto, M; Komiyama, T; Kuroda, S; Morio, A; Morita, Y; Nomura, A; Ohtani, K; Ozaki, N; Sakai, A; Sekine, Y; Sora, I; Tanaka, Y; Uchida, N; Ujike, H; Yamada, M | 1 |
Furukawa, T; Harano, M; Ikeda, M; Inada, T; Iwata, N; Iyo, M; Kitajima, T; Komiyama, T; Nishiyama, T; Ozaki, N; Sekine, Y; Sora, I; Suzuki, T; Ujike, H; Yamada, M; Yamanouchi, Y | 1 |
Harano, M; Ikeda, M; Inada, T; Iwata, N; Iyo, M; Kinoshiya, Y; Kitajima, T; Komiyama, T; Ozaki, N; Sekine, Y; Sora, I; Suzuki, T; Ujike, H; Yamada, M; Yamanouchi, Y | 1 |
Choi, B; Kim, DJ; Kim, TS; Kwon, DH; Lee, H; Lyoo, IK; Pae, CU; Yoon, SJ | 1 |
Harano, M; Hata, H; Ide, S; Ikeda, K; Inada, T; Itokawa, M; Iwata, N; Iyo, M; Kobayashi, H; Komiyama, T; Naka, M; Numachi, Y; Ozaki, N; Sekine, Y; Sora, I; Ujike, H; Yamada, M | 1 |
Nabeshima, T; Nagai, T; Nitta, A; Niwa, M; Yamada, K; Yan, Y | 1 |
Roper, JD | 1 |
Harano, M; Hori, T; Inada, T; Iwata, N; Iyo, M; Kishimoto, M; Komiyama, T; Kotaka, T; Kuroda, S; Motohashi, Y; Okahisa, Y; Ozaki, N; Sekine, Y; Sora, I; Tanaka, Y; Ujike, H; Yamada, M | 1 |
Harano, M; Hori, T; Inada, T; Iwata, N; Iyo, M; Kishimoto, M; Komiyama, T; Kotaka, T; Kuroda, S; Morita, Y; Okahisa, Y; Ozaki, N; Sekine, Y; Sora, I; Tanaka, Y; Ujike, H; Yamada, M | 1 |
Harano, M; Hashimoto, K; Hata, A; Inada, T; Iwata, N; Iyo, M; Komiyama, T; Maeda, K; Mashimo, Y; Matsuzawa, D; Miyatake, R; Ozaki, N; Sawa, A; Sekine, Y; Shimizu, E; Shirayama, Y; Sora, I; Suzuki, Y; Ujike, H; Yamada, M | 1 |
Chen, CK; Chiang, SC; Chiang, YL; Hsiao, CC; Huang, MC; Lin, SK; Liu, HC; Ree, SC; Su, LW | 1 |
Harano, M; Hori, T; Inada, T; Iwata, N; Iyo, M; Komiyama, T; Kotaka, T; Kuroda, S; Okahisa, Y; Otani, K; Ozaki, N; Sakai, A; Sekine, Y; Sora, I; Ujike, H; Yamada, M | 1 |
Ujike, H | 1 |
Goto, K; Ikemoto, S; Yui, K | 1 |
8 review(s) available for methamphetamine and Genetic Predisposition
Article | Year |
---|---|
Genetics of methamphetamine use disorder: A systematic review and meta-analyses of gene association studies.
Topics: Amphetamine-Related Disorders; Brain-Derived Neurotrophic Factor; Genetic Association Studies; Genetic Predisposition to Disease; Genome-Wide Association Study; Genotype; Humans; Methamphetamine; Polymorphism, Single Nucleotide | 2021 |
BDNF rs6265 polymorphism and drug addiction: a systematic review and meta-analysis.
Topics: Alcohols; Asian People; Brain-Derived Neurotrophic Factor; Genetic Predisposition to Disease; Genotype; Heroin; Heroin Dependence; Humans; Methamphetamine; Polymorphism, Genetic; Substance-Related Disorders | 2013 |
A significant association between BDNF promoter methylation and the risk of drug addiction.
Topics: Amphetamine-Related Disorders; Brain-Derived Neurotrophic Factor; Cell Line; DNA Methylation; Female; Genetic Predisposition to Disease; HEK293 Cells; Heroin Dependence; Humans; Male; Methamphetamine; Promoter Regions, Genetic | 2016 |
Genes and molecules that can potentiate or attenuate psychostimulant dependence: relevance of data from animal models to human addiction.
Topics: Adaptation, Physiological; Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Conditioning, Classical; Discrimination Learning; Drug Tolerance; Genetic Predisposition to Disease; Humans; Methamphetamine; Mice; Models, Animal; Motor Activity; Nerve Tissue Proteins; Rats; Self Administration; Species Specificity; Substance Withdrawal Syndrome; Tissue Plasminogen Activator; Tumor Necrosis Factor-alpha | 2008 |
Methamphetamine-associated psychosis.
Topics: Animals; Central Nervous System Stimulants; Genetic Predisposition to Disease; Humans; Methamphetamine; Psychoses, Substance-Induced | 2012 |
Stimulant methamphetamine and dextromethorphan use among Thai adolescents: implications for health of women and children.
Topics: Adolescent; Central Nervous System Stimulants; Child; Dextromethorphan; Female; Genetic Predisposition to Disease; Humans; Infant; Infant, Newborn; Methamphetamine; Neonatal Abstinence Syndrome; Pregnancy; Substance Abuse Detection; Substance-Related Disorders; Thailand | 2012 |
Drugs of abuse and increased risk of psychosis development.
Topics: Age of Onset; Animals; Behavioral Symptoms; Brain; Cannabis; Dopamine; Dopamine Uptake Inhibitors; Functional Neuroimaging; Genetic Predisposition to Disease; Glutamic Acid; Humans; Illicit Drugs; Methamphetamine; Models, Animal; Psychoses, Substance-Induced; Risk Factors; Schizophrenia; Substance-Related Disorders | 2012 |
[Potential genetic predictors for individual vulnerability to substance dependence].
Topics: Carrier Proteins; Dysbindin; Dystrophin-Associated Proteins; Forecasting; Genetic Predisposition to Disease; Glutathione S-Transferase pi; Glutathione Transferase; Glycine Plasma Membrane Transport Proteins; Haplotypes; Humans; Methamphetamine; Odds Ratio; Polymorphism, Single Nucleotide; Psychoses, Substance-Induced; Risk; Substance-Related Disorders | 2008 |
56 other study(ies) available for methamphetamine and Genetic Predisposition
Article | Year |
---|---|
A quantitative trait variant in Gabra2 underlies increased methamphetamine stimulant sensitivity.
Topics: Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Female; Genetic Predisposition to Disease; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Mutation; Quantitative Trait Loci; Quantitative Trait, Heritable; Receptors, GABA-A | 2021 |
Association of GABA receptor delta subunit gene variations with increased risk of methamphetamine dependence.
Topics: Amphetamine-Related Disorders; Case-Control Studies; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Male; Methamphetamine; Polymorphism, Single Nucleotide; Receptors, GABA | 2023 |
FAAH levels and its genetic polymorphism association with susceptibility to methamphetamine dependence.
Topics: Adult; Alleles; Amidohydrolases; Amphetamine-Related Disorders; Asian People; Case-Control Studies; China; Female; Genetic Predisposition to Disease; Genotype; Humans; Leukocytes, Mononuclear; Male; Methamphetamine; Middle Aged; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Young Adult | 2020 |
Changes of
Topics: Adult; Amphetamine-Related Disorders; Animals; Base Sequence; Biomarkers; Brain-Derived Neurotrophic Factor; Corpus Striatum; Disease Models, Animal; DNA Methylation; Exons; Female; Gene Expression Regulation; Genetic Predisposition to Disease; Hippocampus; Humans; Male; Methamphetamine; Rats; Sequence Analysis, DNA; Thailand; Young Adult | 2021 |
Verification of a genetic locus for methamphetamine intake and the impact of morphine.
Topics: Animals; Choice Behavior; Chromosomes, Mammalian; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Genetic Loci; Genetic Predisposition to Disease; Methamphetamine; Mice, Inbred C57BL; Mice, Inbred DBA; Morphine; Reproducibility of Results; Saccharin; Tritium | 2018 |
Genetic variation of GRIA3 gene is associated with vulnerability to methamphetamine dependence and its associated psychosis.
Topics: Adult; Amphetamine-Related Disorders; Asian People; Brain-Derived Neurotrophic Factor; Case-Control Studies; Central Nervous System Stimulants; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Humans; Male; Methamphetamine; Middle Aged; Polymorphism, Single Nucleotide; Psychoses, Substance-Induced; Psychotic Disorders; Receptors, AMPA; Schizophrenia; Young Adult | 2018 |
Parallel Effects of Methamphetamine on Anxiety and CCL3 in Humans and a Genetic Mouse Model of High Methamphetamine Intake.
Topics: Adult; Amphetamine-Related Disorders; Animals; Anxiety; Central Nervous System Stimulants; Chemokine CCL3; Disease Models, Animal; Female; Follow-Up Studies; Genetic Predisposition to Disease; Hippocampus; Humans; Male; Methamphetamine; Mice, Inbred C57BL; Mice, Inbred DBA; Middle Aged; RNA, Messenger; Treatment Outcome | 2017 |
Adverse effect of catechol-O-methyltransferase (COMT) Val158Met met/met genotype in methamphetamine-related executive dysfunction.
Topics: Adolescent; Adult; Aged; Amphetamine-Related Disorders; Catechol O-Methyltransferase; Dopamine; Executive Function; Genetic Predisposition to Disease; Genotype; Humans; Male; Methamphetamine; Middle Aged; Polymorphism, Single Nucleotide; Prefrontal Cortex; Stroop Test; Trail Making Test; Wisconsin Card Sorting Test; Young Adult | 2019 |
Association of a functional FAAH polymorphism with methamphetamine-induced symptoms and dependence in a Malaysian population.
Topics: Adult; Amidohydrolases; Amphetamine-Related Disorders; Case-Control Studies; Genetic Association Studies; Genetic Predisposition to Disease; Humans; Male; Methamphetamine; Panic Disorder; Phenotype; Polymorphism, Genetic; Psychoses, Substance-Induced; Substance-Related Disorders | 2013 |
Evidence for shared genetic risk between methamphetamine-induced psychosis and schizophrenia.
Topics: Alleles; Amphetamine-Related Disorders; Asian People; Case-Control Studies; Female; Genetic Predisposition to Disease; Genome-Wide Association Study; Humans; Male; Methamphetamine; Polymorphism, Single Nucleotide; Psychoses, Substance-Induced; Schizophrenia | 2013 |
Polymorphisms in CYP2D6 may predict methamphetamine related heart failure.
Topics: Adult; Amphetamine-Related Disorders; Biomarkers; Cardiomyopathy, Dilated; Case-Control Studies; Central Nervous System Stimulants; Chi-Square Distribution; Cytochrome P-450 CYP2D6; Female; Gas Chromatography-Mass Spectrometry; Genetic Predisposition to Disease; Heart Failure; Humans; Logistic Models; Male; Methamphetamine; Middle Aged; Natriuretic Peptide, Brain; Odds Ratio; Phenotype; Pilot Projects; Polymorphism, Genetic; Predictive Value of Tests; Prospective Studies; Risk Assessment; Risk Factors; Substance Abuse Detection | 2013 |
Impaired memory and reduced sensitivity to the circadian period lengthening effects of methamphetamine in mice selected for high methamphetamine consumption.
Topics: Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Circadian Rhythm; Drug-Seeking Behavior; Female; Genetic Predisposition to Disease; Hippocampus; Male; Memory Disorders; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Motor Activity; Receptors, AMPA; Self Administration; Species Specificity | 2013 |
Genetic factors involved in risk for methamphetamine intake and sensitization.
Topics: Animals; Brain; Gene Regulatory Networks; Genetic Predisposition to Disease; Genotype; Humans; Male; Methamphetamine; Mice; Quantitative Trait Loci; Receptors, Opioid, mu; Substance-Related Disorders | 2013 |
Clinical features of methamphetamine-induced paranoia and preliminary genetic association with DBH-1021C→T in a Thai treatment cohort.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Dopamine beta-Hydroxylase; Female; Genetic Association Studies; Genetic Predisposition to Disease; Genotype; Humans; Male; Methamphetamine; Middle Aged; Paranoid Disorders; Polymorphism, Restriction Fragment Length; Psychoses, Substance-Induced; Thailand; Young Adult | 2014 |
Methamphetamine drinking microstructure in mice bred to drink high or low amounts of methamphetamine.
Topics: Amphetamine-Related Disorders; Animals; Breeding; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Drinking Behavior; Drinking Water; Female; Genetic Predisposition to Disease; Methamphetamine; Mice; Photoperiod; Self Administration; Species Specificity | 2014 |
The Effects of BDNF Val66Met Gene Polymorphism on Serum BDNF and Cognitive Function in Methamphetamine-Dependent Patients and Normal Controls: A Case-Control Study.
Topics: Adult; Amphetamine-Related Disorders; Brain-Derived Neurotrophic Factor; Case-Control Studies; Cognition Disorders; Female; Genetic Predisposition to Disease; Genotype; Humans; Male; Methamphetamine; Middle Aged; Polymorphism, Single Nucleotide; Young Adult | 2015 |
Associations between the orexin (hypocretin) receptor 2 gene polymorphism Val308Ile and nicotine dependence in genome-wide and subsequent association studies.
Topics: Abdomen; Adolescent; Adult; Aged; Aged, 80 and over; Asian People; Autopsy; Female; Genetic Loci; Genetic Predisposition to Disease; Genome-Wide Association Study; Goiter; Humans; Male; Methamphetamine; Middle Aged; Orexin Receptors; Pain, Postoperative; Physical Chromosome Mapping; Polymorphism, Single Nucleotide; Reproducibility of Results; Schizotypal Personality Disorder; Tobacco Use Disorder; Young Adult | 2015 |
Developmental stress elicits preference for methamphetamine in the spontaneously hypertensive rat model of attention-deficit/hyperactivity disorder.
Topics: Animals; Attention; Attention Deficit Disorder with Hyperactivity; Disease Models, Animal; Female; Genetic Predisposition to Disease; Hypertension; Learning; Male; Maternal Deprivation; Methamphetamine; Rats; Rats, Inbred WKY; Rats, Sprague-Dawley; Rats, Wistar; Stress, Psychological | 2016 |
Methamphetamine-induced psychosis is associated with DNA hypomethylation and increased expression of AKT1 and key dopaminergic genes.
Topics: Adult; Amphetamine-Related Disorders; Case-Control Studies; Catechol O-Methyltransferase; DNA Methylation; Dopamine; Epigenomics; Female; Genetic Predisposition to Disease; Humans; Male; Methamphetamine; Promoter Regions, Genetic; Proto-Oncogene Proteins c-akt; Psychotic Disorders; Receptors, Dopamine D3; Receptors, Dopamine D4; Saliva; Transcriptome | 2016 |
Effects of alcohol on c-Myc protein in the brain.
Topics: Alcoholism; Animals; Brain; Central Nervous System Depressants; Central Nervous System Stimulants; Chlorocebus aethiops; Cyclin-Dependent Kinase Inhibitor p21; Disease Models, Animal; Ethanol; Gene Expression Regulation; Genetic Predisposition to Disease; Methamphetamine; Mice; Mice, Knockout; Proto-Oncogene Proteins c-myc; Receptors, Metabotropic Glutamate | 2017 |
Association study between the PIK4CA gene and methamphetamine use disorder in a Japanese population.
Topics: Adult; Aged; Alleles; Amphetamine-Related Disorders; Asian People; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Haplotypes; Humans; Male; Methamphetamine; Middle Aged; Minor Histocompatibility Antigens; Phosphotransferases (Alcohol Group Acceptor); Psychotic Disorders | 2009 |
Association study between casein kinase 1 epsilon gene and methamphetamine dependence.
Topics: Adult; Amphetamine-Related Disorders; Animals; Asian People; Casein Kinase 1 epsilon; Dopamine and cAMP-Regulated Phosphoprotein 32; Dopamine Uptake Inhibitors; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Male; Methamphetamine; Mice; Middle Aged; Phenotype; Polymorphism, Genetic; Psychoses, Substance-Induced; Second Messenger Systems | 2008 |
Short allele of 5-HTTLPR as a risk factor for the development of psychosis in Japanese methamphetamine abusers.
Topics: Adult; Aged; Asian People; Central Nervous System Stimulants; Drug Users; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Male; Methamphetamine; Middle Aged; Polymorphism, Genetic; Psychoses, Substance-Induced; Receptor, Serotonin, 5-HT1A; Risk Factors; Serotonin Plasma Membrane Transport Proteins; Young Adult | 2008 |
Association study of the calcineurin A gamma subunit gene (PPP3CC) and methamphetamine-use disorder in a Japanese population.
Topics: Amphetamine-Related Disorders; Asian People; Calcineurin; Case-Control Studies; Central Nervous System Stimulants; Gene Frequency; Genetic Predisposition to Disease; Genotype; Haplotypes; Humans; Methamphetamine; Polymorphism, Single Nucleotide; Psychoses, Substance-Induced; Schizophrenia | 2008 |
Genetic variants of D2 but not D3 or D4 dopamine receptor gene are associated with rapid onset and poor prognosis of methamphetamine psychosis.
Topics: Adult; Case-Control Studies; Central Nervous System Stimulants; DNA Mutational Analysis; Female; Gene Frequency; Genetic Predisposition to Disease; Genetic Variation; Genotype; Glycine; Humans; Male; Methamphetamine; Middle Aged; Minisatellite Repeats; Prognosis; Psychoses, Substance-Induced; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Dopamine D4; Serine; Statistics, Nonparametric | 2009 |
An association study of monoamine oxidase A (MAOA) gene polymorphism in methamphetamine psychosis.
Topics: Adolescent; Adult; Aged; Dopamine Agents; Female; Gene Frequency; Genetic Predisposition to Disease; Humans; Male; Methamphetamine; Middle Aged; Monoamine Oxidase; Polymorphism, Genetic; Psychoses, Substance-Induced; Sex Factors; Substance-Related Disorders; Young Adult | 2009 |
G72 gene is associated with susceptibility to methamphetamine psychosis.
Topics: Adult; Carrier Proteins; Case-Control Studies; Female; Genetic Predisposition to Disease; Humans; Intracellular Signaling Peptides and Proteins; Male; Methamphetamine; Middle Aged; Polymorphism, Single Nucleotide; Psychoses, Substance-Induced; Psychotic Disorders | 2009 |
Genetically correlated effects of selective breeding for high and low methamphetamine consumption.
Topics: Administration, Oral; Amphetamine-Related Disorders; Animals; Apoptosis; Avoidance Learning; Breeding; Central Nervous System Stimulants; Conditioning, Psychological; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Gene Expression Regulation; Genetic Predisposition to Disease; Genotype; Immune System; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Motivation; Phenotype; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-rel; Receptors, Serotonin, 5-HT3; Self Administration; Serotonin Plasma Membrane Transport Proteins | 2009 |
A major QTL on chromosome 11 influences psychostimulant and opioid sensitivity in mice.
Topics: Analgesics, Opioid; Animals; Central Nervous System Stimulants; Drug Resistance; Female; Genetic Predisposition to Disease; Haplotypes; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Neurologic Mutants; Motor Activity; Quantitative Trait Loci; Receptors, Opioid, mu; Substance-Related Disorders | 2009 |
Association analysis of GRM2 and HTR2A with methamphetamine-induced psychosis and schizophrenia in the Japanese population.
Topics: Amphetamine-Related Disorders; Asian People; Case-Control Studies; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genotype; Haplotypes; Humans; Japan; Methamphetamine; Mutation; Polymorphism, Single Nucleotide; Psychoses, Substance-Induced; Receptor, Serotonin, 5-HT2A; Receptors, Metabotropic Glutamate; Regression Analysis; Schizophrenia | 2010 |
Preliminary evidence of ethnic divergence in associations of putative genetic variants for methamphetamine dependence.
Topics: Adult; Amphetamine-Related Disorders; Arrestins; Asian People; beta-Arrestin 2; beta-Arrestins; Brain-Derived Neurotrophic Factor; Case-Control Studies; Confidence Intervals; Ethnicity; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genotype; Glutathione S-Transferase pi; Humans; Male; Methamphetamine; Middle Aged; Odds Ratio; Polymorphism, Single Nucleotide; White People | 2010 |
PROKR2 is associated with methamphetamine dependence in the Japanese population.
Topics: Adult; Alleles; Amphetamine-Related Disorders; Asian People; Case-Control Studies; Chi-Square Distribution; Female; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genotype; Haplotypes; Humans; Male; Methamphetamine; Middle Aged; Polymorphism, Single Nucleotide; Receptors, G-Protein-Coupled; Receptors, Peptide | 2010 |
Genetic analysis of the rhabdomyolysis-associated genes in forensic autopsy cases of methamphetamine abusers.
Topics: Acyl-CoA Dehydrogenase, Long-Chain; Adult; Autopsy; Carnitine O-Palmitoyltransferase; Cytochrome P-450 CYP2D6; Female; Forensic Genetics; Genetic Predisposition to Disease; Humans; Immunohistochemistry; Japan; Male; Methamphetamine; Middle Aged; Polymorphism, Genetic; Rhabdomyolysis; Ryanodine Receptor Calcium Release Channel | 2011 |
Selective breeding for magnitude of methamphetamine-induced sensitization alters methamphetamine consumption.
Topics: Amphetamine-Related Disorders; Animals; Behavior, Animal; Breeding; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Genetic Predisposition to Disease; Methamphetamine; Mice; Mice, Inbred Strains; Motor Activity; Selection, Genetic; Stereotyped Behavior | 2011 |
Decreased level of Nurr1 in heterozygous young adult mice leads to exacerbated acute and long-term toxicity after repeated methamphetamine exposure.
Topics: Animals; Dopamine; Dopamine Plasma Membrane Transport Proteins; Electrochemistry; Gene Expression Regulation; Genetic Predisposition to Disease; Heterozygote; Male; Methamphetamine; Mice; Mutation; Nuclear Receptor Subfamily 4, Group A, Member 2; Substantia Nigra; Tyrosine 3-Monooxygenase | 2010 |
Dopamine receptor D3 genetic polymorphism (rs6280TC) is associated with rates of cognitive impairment in methamphetamine-dependent men with HIV: preliminary findings.
Topics: Adult; Alleles; Amphetamine-Related Disorders; Cognition Disorders; Dopamine; Genetic Predisposition to Disease; Genotype; HIV; HIV Infections; Humans; Male; Methamphetamine; Neuropsychological Tests; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Receptors, Dopamine D3; Retrospective Studies; Risk Factors | 2011 |
Lack of association between translin-associated factor X gene (TSNAX) and methamphetamine dependence in the Japanese population.
Topics: Alleles; Amphetamine-Related Disorders; Asian People; Bipolar Disorder; Case-Control Studies; Central Nervous System Stimulants; Depressive Disorder, Major; DNA-Binding Proteins; Female; Genetic Predisposition to Disease; Genotype; Haplotypes; HapMap Project; Humans; Male; Methamphetamine; Nerve Tissue Proteins; Polymorphism, Single Nucleotide; Schizophrenia | 2011 |
Lack of association between the Val158Met catechol-O-methyltransferase gene polymorphism and methamphetamine dependence.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Catechol O-Methyltransferase; Central Nervous System Stimulants; Czech Republic; Family Health; Female; Gene Frequency; Genetic Predisposition to Disease; Haplotypes; Humans; Male; Methamphetamine; Point Mutation; Polymorphism, Genetic; Psychotic Disorders; Young Adult | 2011 |
A COMT gene haplotype associated with methamphetamine abuse.
Topics: Adolescent; Adult; Armadillo Domain Proteins; Catechol O-Methyltransferase; Child; Computational Biology; DiGeorge Syndrome; Enzyme Assays; Female; Gene Expression Regulation, Enzymologic; Genetic Predisposition to Disease; Haplotypes; Humans; Luciferases; Male; Methamphetamine; Middle Aged; Polymorphism, Single Nucleotide; RNA, Messenger; Substance-Related Disorders; Young Adult | 2011 |
Congenic dissection of a major QTL for methamphetamine sensitivity implicates epistasis.
Topics: Animals; Central Nervous System Stimulants; Chromosome Mapping; Epistasis, Genetic; Gene-Environment Interaction; Genetic Predisposition to Disease; Genotype; Methamphetamine; Mice; Mice, Congenic; Motor Activity; Quantitative Trait Loci | 2012 |
Effects of methamphetamine abuse and serotonin transporter gene variants on aggression and emotion-processing neurocircuitry.
Topics: Adult; Aggression; Alleles; Amphetamine-Related Disorders; Amygdala; Brain; Brain Mapping; Central Nervous System Stimulants; Emotions; Facial Expression; Female; Frontal Lobe; Genetic Predisposition to Disease; Genetic Variation; Genotype; Humans; Introns; Magnetic Resonance Imaging; Male; Methamphetamine; Middle Aged; Minisatellite Repeats; Nerve Net; Occipital Lobe; Pattern Recognition, Visual; Prefrontal Cortex; Serotonin Plasma Membrane Transport Proteins; Substance Withdrawal Syndrome; Surveys and Questionnaires | 2012 |
Nine- or fewer repeat alleles in VNTR polymorphism of the dopamine transporter gene is a strong risk factor for prolonged methamphetamine psychosis.
Topics: Adult; Amphetamine-Related Disorders; Dopamine Plasma Membrane Transport Proteins; Female; Gene Frequency; Genetic Predisposition to Disease; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; Minisatellite Repeats; Nerve Tissue Proteins; Polymorphism, Genetic; Psychoses, Substance-Induced | 2003 |
Candidate genes, pathways and mechanisms for bipolar (manic-depressive) and related disorders: an expanded convergent functional genomics approach.
Topics: Animals; Antimanic Agents; Bayes Theorem; Bipolar Disorder; Brain; Central Nervous System Stimulants; Disease Models, Animal; Dopamine and cAMP-Regulated Phosphoprotein 32; Enkephalins; Gene Expression Profiling; Genetic Linkage; Genetic Predisposition to Disease; Genetic Testing; Genomics; Humans; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Microarray Analysis; Nerve Tissue Proteins; Pharmacogenetics; Phosphoproteins; Protein Precursors; Substance P; Tachykinins; Valproic Acid | 2004 |
A nonsynonymous polymorphism in the human fatty acid amide hydrolase gene did not associate with either methamphetamine dependence or schizophrenia.
Topics: Adult; Age of Onset; Amidohydrolases; Amino Acid Sequence; Amino Acid Substitution; Amphetamine-Related Disorders; Cannabinoid Receptor Modulators; Case-Control Studies; DNA Mutational Analysis; Female; Gene Frequency; Genetic Predisposition to Disease; Genetic Testing; Genotype; Humans; Japan; Male; Methamphetamine; Middle Aged; Mutation; Polymorphism, Genetic; Schizophrenia | 2005 |
Haplotype association between GABAA receptor gamma2 subunit gene (GABRG2) and methamphetamine use disorder.
Topics: Adolescent; Adult; Aged; Algorithms; Alleles; Amphetamine-Related Disorders; Case-Control Studies; Central Nervous System Stimulants; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Haplotypes; Humans; Linkage Disequilibrium; Male; Methamphetamine; Middle Aged; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Psychiatric Status Rating Scales; Receptors, GABA-A; Receptors, GABA-B; Schizophrenia | 2005 |
Positive association of AKT1 haplotype to Japanese methamphetamine use disorder.
Topics: Adult; Amphetamine-Related Disorders; Case-Control Studies; Female; Gene Frequency; Genetic Predisposition to Disease; Haplotypes; Humans; Japan; Male; Methamphetamine; Polymorphism, Single Nucleotide; Proto-Oncogene Proteins c-akt | 2006 |
Ghrelin precursor gene polymorphism and methamphetamine dependence in the Korean population.
Topics: Adult; Central Nervous System Stimulants; Female; Genetic Predisposition to Disease; Genotype; Ghrelin; Humans; Korea; Male; Methamphetamine; Middle Aged; Motilin; Polymorphism, Genetic; Reverse Transcriptase Polymerase Chain Reaction; Substance-Related Disorders | 2005 |
Association analysis of delta-opioid receptor gene polymorphisms in methamphetamine dependence/psychosis.
Topics: Adult; Alleles; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Japan; Linkage Disequilibrium; Male; Methamphetamine; Middle Aged; Polymorphism, Single Nucleotide; Psychoses, Substance-Induced; Receptors, Opioid, delta | 2006 |
Enduring vulnerability to reinstatement of methamphetamine-seeking behavior in glial-cell-line-derived neurotrophic factor mutant mice.
Topics: Amphetamine-Related Disorders; Animals; Appetitive Behavior; Catheters, Indwelling; Conditioning, Operant; Cues; Extinction, Psychological; Feeding Behavior; Food Deprivation; Genetic Predisposition to Disease; Glial Cell Line-Derived Neurotrophic Factor; Heterozygote; Infusion Pumps; Infusions, Intravenous; Male; Methamphetamine; Mice; Mice, Knockout; Motivation; Recurrence; Reinforcement, Psychology; Self Administration | 2007 |
Drug-endangered children and the manufacture of methamphetamine.
Topics: Adolescent; Amphetamine-Related Disorders; Behavior, Addictive; Child; Community Participation; Female; Fetus; Genetic Predisposition to Disease; Health Education; Health Services Needs and Demand; Humans; Male; Methamphetamine; Nurse's Role; Pleasure-Pain Principle; Pregnancy; Reinforcement, Psychology; Risk Factors; Safety Management; School Nursing | 2007 |
The dysbindin gene (DTNBP1) is associated with methamphetamine psychosis.
Topics: Adult; Carrier Proteins; Case-Control Studies; DNA Mutational Analysis; Dysbindin; Dystrophin-Associated Proteins; Female; Genetic Predisposition to Disease; Humans; Male; Methamphetamine; Middle Aged; Polymorphism, Single Nucleotide; Psychoses, Substance-Induced; Statistics, Nonparametric | 2008 |
The glycine transporter 1 gene (GLYT1) is associated with methamphetamine-use disorder.
Topics: Adult; Amphetamine-Related Disorders; Case-Control Studies; Female; Genetic Predisposition to Disease; Genotype; Glycine Plasma Membrane Transport Proteins; Humans; Male; Methamphetamine; Middle Aged; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Psychoses, Substance-Induced | 2008 |
Identification of functional polymorphisms in the promoter region of the human PICK1 gene and their association with methamphetamine psychosis.
Topics: Adolescent; Adult; Aged; Amphetamine-Related Disorders; Asian People; Carrier Proteins; Dopamine Plasma Membrane Transport Proteins; Female; Gene Frequency; Genetic Predisposition to Disease; Haplotypes; Humans; Inteins; Japan; Male; Methamphetamine; Middle Aged; Nuclear Proteins; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Prognosis; Promoter Regions, Genetic; Psychoses, Substance-Induced; Transcription Factors | 2007 |
Analysis of association of clinical correlates and 5-HTTLPR polymorphism with suicidal behavior among Chinese methamphetamine abusers.
Topics: Adult; Alleles; Amphetamine-Related Disorders; Asian People; Comorbidity; Depressive Disorder; Female; Genetic Predisposition to Disease; Genotype; Humans; Male; Methamphetamine; Polymorphism, Genetic; Promoter Regions, Genetic; Psychoses, Substance-Induced; Risk Factors; Serotonin Plasma Membrane Transport Proteins; Statistics as Topic; Suicide, Attempted; Taiwan | 2007 |
Reduced CYP2D6 activity is a negative risk factor for methamphetamine dependence.
Topics: Adult; Amphetamine-Related Disorders; Brain; Brain Diseases, Metabolic; Case-Control Studies; Central Nervous System Stimulants; Cytochrome P-450 CYP2D6; DNA Mutational Analysis; Down-Regulation; Female; Gene Expression Regulation, Enzymologic; Gene Frequency; Genetic Predisposition to Disease; Genetic Testing; Genotype; Humans; Inactivation, Metabolic; Japan; Male; Methamphetamine; Middle Aged; Risk Factors | 2008 |
Factors for susceptibility to episode recurrence in spontaneous recurrence of methamphetamine psychosis.
Topics: Dopamine; Female; Genetic Predisposition to Disease; Humans; Methamphetamine; Norepinephrine; Prisoners; Psychotic Disorders; Recurrence; Reference Values; Stress, Psychological; Substance-Related Disorders; Tyrosine | 2002 |